CDKN2A/p16INK4a Monoclonal Antibody-MB10720

CDKN2A/p16INK4a Monoclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: MB10720-50, MB10720-100

Product: 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA

Swiss-Prot: P42771

Host: Rabbit

Reactivity: Human, Mouse

Applications: WB, ICC/IF

All Applications: WB: 1/500-1/1000 IF: 1/50-1/200

Background: p16-INK4A a cell-cycle regulatory protein that Interacts with CDK4 and CDK6, inhibiting their ability to interact with cyclins D. Inhibits the phosphorylation of the retinoblastoma protein by CDK4 or CDK6. Four alternatively spliced isoforms have been reported.

Purification and Purity: Affinity Purified

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: IgG

Bioworld Molecular Weight: Calculated MW: 17 kDa; Observed MW: 17 kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Western blot analysis of CDKN2A/p16INK4a in 293 lysates using CDKN2A antibody., Western blot analysis of CDKN2Ap16INK4a in 3T3, Hela lysates using CDKN2A/p16INK4a antibody., Immunocytochemistry analysis of CDKN2A/p16INK4a in Hela using CDKN2A/p16INK4a antibody, and DAPI

Alternative Name: CDKN2A; CDKN2; MTS1; Cyclin-dependent kinase inhibitor 2A; isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A

Immunogen: Recombinant protein of human CDKN2A/p16INK4a

Conjugate: Unconjugated

Modification: Unmodified